植物遺伝学および育種ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Current synopsis: The source: cannabinoids

Jill Woodworth

To manage a diagnosis of TSC one must broaden the scope of germ theory. Focusing on individual manifes­tations without overall integration and oversight of all specialists treating requires solid supports and intricate case management overtime to gain any measure of sta­bility, minimize the impact of manifestations and maintain overall health. Quality of life is significantly strained and diminished over time in many cases as support networks become more siloed, with all communication between providers implemented by a caregiver. Medications are prescribed by multiple parties with little long-term over­sight of cumulative side effects and interactions over time. One must become subservient to the healthcare systems inclusive of behavioural and mental health services, as well as educational settings. The assumption that the profes­sionals from whom we are seeking treatment and support know more about the condition and therefore the key to case management is wrangling experts in specialities and seeking to integrate the most progressive research and treatments, all while holding on to intense patient history and respectfully bow to the top-heavy power struc­ture of modern medicine to guide. There is less of a top-heavy power structure and the use of cannabinoid medi­cine requires much patient involvement and education so eventually, it is managed solely by the individual.